Boğaziçi University faculty member Prof. Dr. Rana Sanyal's contribution to the Phase 1 success of Türkiye's first original drug candidate to reach clinical trials.
RS Research, which carries out drug development activities by initiating fundamental scientific research within Boğaziçi University’s infrastructure, has successfully completed the Phase 1 clinical trial of Türkiye’s first original drug candidate.
